Ironwood Pharmaceuticals | IRWD - Capital Ordinário

Preço das Ações
3.04
Mudança Diária
-0.19 -5.88%
Mensal
-18.93%
Anual
115.60%
Q1 Previsão
2.95




Capital Ordinário Alterar Data
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Agios Pharmaceuticals USD 58.45M 169K 2025-12
Akebia Therapeutics USD 265.42M 199K 2025-12
Almirall EUR 214.79M 0 2025-12
Alnylam Pharmaceuticals USD 132.38M 585K 2025-12
Amarin USD 20.81M 13K 2025-12
Ardelyx USD 244.35M 1.38M 2025-12
Astellas Pharma JPY 1.79B 195K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Charles River Laboratories USD 49.22M 2K 2025-12
Coherus Biosciences USD 121.16M 4.92M 2025-12
Emergent BioSolutions USD 100K 0 2023-06
Esperion Therapeutics USD 245.22M 39.79M 2025-12
Exact Sciences USD 189.45M 232K 2025-09
Halozyme Therapeutics USD 117.78M 259K 2025-12
Incyte USD 198.46M 2.33M 2025-12
Ironwood Pharmaceuticals USD 160K 0 2024-12
Karyopharm Therapeutics USD 13K 0 2024-09
Lexicon Pharmaceuticals USD 363.47M 67K 2025-12
MacroGenics USD 63.32M 60K 2025-12
Moderna USD 391M 2M 2025-09
Myriad Genetics USD 93.5M 400K 2025-12
Pacira USD 41.12M 1.85M 2025-12
PTC Therapeutics USD 81.47M 1.54M 2025-12
Puma Biotechnology USD 5K 0 2024-06
Sarepta Therapeutics USD 104.96M 196K 2025-12
Takeda JPY 1.58B 2K 2025-12
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vanda Pharmaceuticals USD 58K 0 2024-12